The pharmaceutical industry stands at a pivotal moment, with artificial intelligence (AI) emerging as a transformative force in the complex and costly landscape of drug discovery and development. A compelling…
In a significant stride towards modernizing pharmaceutical innovation, Takeda Pharmaceutical has embarked on a transformative journey, leveraging artificial intelligence (AI) to redefine its research and development (R&D) pipeline. This strategic…
Eli Lilly and Company, along with a consortium of other pharmaceutical firms, has formally expressed its support for the U.S. Securities and Exchange Commission’s (SEC) proposed rule change that would…
AstraZeneca PLC (AZN), a global biopharmaceutical giant, has solidified a significant strategic partnership with CSPC Pharmaceutical Group Limited (CSPCY), one of China’s leading pharmaceutical companies, for the development and commercialization…
The pharmaceutical and life sciences sector is confronting an increasingly intricate landscape of regulatory scrutiny, expanding environmental, social, and governance (ESG) obligations, and intensifying geopolitical pressures that are reshaping global…
